Firmonertinib Mesilate Tablets · Oncology Firmonertinib mesilate is a third-generation EGFR tyrosine kinase inhibitor that irreversibly binds to and inhibits mutant EGFR, including T790M resistance mutations.
Furmonertinib Mesilate Tablets · Oncology Furmonertinib is a third-generation EGFR tyrosine kinase inhibitor that irreversibly binds to and inhibits mutant EGFR, including T790M resistance mutations.
JAB-21822 · Oncology JAB-21822 is a selective inhibitor of fibroblast growth factor receptor (FGFR) signaling that blocks aberrant growth signals in cells dependent on FGFR activation.
JAB-3312 · Oncology JAB-3312 is a selective inhibitor of fibroblast growth factor receptor (FGFR) signaling.
Pemetrexed Disodium for Injection · Oncology Pemetrexed is a folate antagonist that inhibits multiple enzymes involved in nucleotide synthesis, disrupting DNA and RNA production in cancer cells.